PAK1 and breast cancer: Consistent with our previous results, we found that breast cancer cells with amplification or overexpression of PAK1 are highly sensitive to cisplatin-induced apoptosis after PAK1 inhibition or depletion, whereas PAK blockade has a very modest effect in HCC1419 breast cancer cells (Figure 3C).